JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fischman, M. W.
Right arrow Articles by Pearlson, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fischman, M. W.
Right arrow Articles by Pearlson, G. D.

Effects of desipramine maintenance on cocaine self-administration by humans

MW Fischman, RW Foltin, G Nestadt and GD Pearlson

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Six research volunteers with histories of cocaine use were tested in a cocaine choice paradigm to investigate the effects of desipramine maintenance on cocaine-taking behavior. Subjects were allowed to self- administer i.v. saline or cocaine (8, 16 or 32 mg) in daily 3-hr sessions to establish baseline levels of self-administration, self- reported effects of the drug and changes in heart rate and blood pressure. Each subject was then maintained on daily doses of desipramine for 3 to 4 weeks, after which a second cocaine self- administration dose-response curve was generated under desipramine maintenance. This maintenance had no effect on cocaine self- administration. There was, however, a significant increase in heart rate and blood pressure during desipramine maintenance. Desipramine maintenance also resulted in a change in the profile of cocaine's self- reported effects. In some cases (e.g., Arousal and Vigor on the Profile of Mood States, Benzedrine Group scale on the Addiction Research Center Inventory), reports of cocaine's effects were significantly reduced under conditions of desipramine maintenance, and in others (e.g., Anxiety, Anger and Confusion on the Profile of Mood States), those reports were significantly increased. Furthermore, there was a significant decrease in subjects response to an "I want cocaine" question while under desipramine maintenance. The data suggest that desipramine does not affect the reinforcing properties of cocaine, but may interfere with its other stimulus properties. Furthermore, the cardiovascular effects of desipramine appear to have the potential for toxicity when that drug is administered in combination with cocaine.

Volume 253, Issue 2, pp. 760-770, 05/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
I. Elman, K. H. Karlsgodt, D. R. Gastfriend, C. F. Chabris, and H. C. Breiter
Cocaine-primed craving and its relationship to depressive symptomatology in individuals with cocaine dependence
J Psychopharmacol, March 1, 2002; 16(2): 163 - 167.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. L. Walsh, B. Geter-Douglas, E. C. Strain, and G. E. Bigelow
Enadoline and Butorphanol: Evaluation of kappa -Agonists on Cocaine Pharmacodynamics and Cocaine Self-Administration in Humans
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 147 - 158.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
A. H. Oliveto, A. Feingold, R. Schottenfeld, P. Jatlow, and T. R. Kosten
Desipramine in Opioid-Dependent Cocaine Abusers Maintained on Buprenorphine vs Methadone
Arch Gen Psychiatry, September 1, 1999; 56(9): 812 - 820.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
F. R. Levin, S. M. Evans, and H. D. Kleber
Alcohol & Drug Abuse: Practical Guidelines for the Treatment of Substance Abusers With Adult Attention-Deficit Hyperactivity Disorder
Psychiatr Serv, August 1, 1999; 50(8): 1001 - 1003.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. E. Jones, B. E. Garrett, and R. R. Griffiths
Subjective and Physiological Effects of Intravenous Nicotine and Cocaine in Cigarette Smoking Cocaine Abusers
J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 188 - 197.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. S. Kleven and W. Koek
Discriminative Stimulus Properties of Cocaine: Enhancement by Monoamine Reuptake Blockers
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1015 - 1025.
[Abstract] [Full Text]


Home page
J PsychopharmacolHome page
S. T. Tiffany and B. L. Carter
Is craving the source of compulsive drug use?
J Psychopharmacol, January 1, 1998; 12(1): 23 - 30.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. M. Knuepfer and Q. Gan
Effects of Proposed Treatments for Cocaine Addiction on Hemodynamic Responsiveness to Cocaine in Conscious Rats
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 592 - 603.
[Abstract] [Full Text]


Home page
ScienceHome page
D. Landry, K Zhao, G. Yang, M Glickman, and T. Georgiadis
Antibody-catalyzed degradation of cocaine
Science, March 26, 1993; 259(5103): 1899 - 1901.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics.